International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.
International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.
Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.
Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.
Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.
International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.
Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.
Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.
Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.
An International Open Access Journal Devoted to General Medicine.
Professor Kubista is the head of the Department of Gene Expression at the Institute of Biotechnology of the Czech Academy of Sciences, founder and CEO of the TATAA Biocenter (www.tataa.com) and founder of Life Genomics (www.lifegenomics.se). He was one of the pioneers contributing to the development of quantitative real-time PCR (qPCR) and introduced qPCR for single-cell expression profiling. He led the development of reagents for high-throughput single-cell expression profiling and quality control at TATAA. He also developed qPCR tomography for intracellular expression profiling. Kubista co-authored the Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines and is member of the CEN and ISO workgroups drafting the guidelines on preanalytics and the consortium CANCER-ID, developing procedures for liquid biopsy analyses for the pharmaceutical industry. Most recently, TATAA Biocenter developed Two-Tailed PCR, which is currently the most sensitive and specific method for microRNA analysis.
For more information on courses, you can visit TATAA Biocenter website.
Place: Mystras Grand Palace, Sparta, Greece
Date: 8-9 October 2019
Time: 9:00 a.m. - 5:00 p.m.
Registration date-time: October 8, 2019; from 8:00 a.m. to 9:00 a.m.
Registration fees: 590 EUR (Academic delegates), 690 EUR (Industrial delegates)
For questions or any further requests please send an email to workshops@spandidos-publications.com.